GENNEX LABORATORIES
Back to Income Statement
|
GENNEX LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹87 Cr | ₹66 Cr | ₹61 Cr | ₹60 Cr | ₹56 Cr |
What is the latest Revenue of GENNEX LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹66 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹56 Cr |
How is Revenue of GENNEX LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 32.18 | |
| Mar2024 | ₹66 Cr | 7.17 | |
| Mar2023 | ₹61 Cr | 2.62 | |
| Mar2022 | ₹60 Cr | 7.25 | |
| Mar2021 | ₹56 Cr | - | |
Compare Revenue of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹253.3 Cr | -7% | -11.4% | -12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -7% |
-11.4% |
-12.1% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses